FindTrial
Sign In

Curcumin and the gut short chain fatty acids

Investigating the effect of curcumin supplementation compared with placebo on the fecal short chain fatty acids of obese people

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200929048876N5
Enrollment
30
Registered
2025-08-14
Start date
2025-09-21
Completion date
Unknown
Last updated
2025-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

obesity. Obesity due to excess calories

Interventions

Intervention 1: Intervention group: Curcumin (500 mg in each capsul). Intervention 2: Control group: maltodextrin (500 mg in each capsul).

Sponsors

Zanjan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Body mass index equal or higher than 30 ages of 18 to 50 year

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Weight alterations. Timepoint: At the baseline and after 8 weeks. Method of measurement: Scale.;Waist circumference alterations. Timepoint: At the baseline and after 8 weeks. Method of measurement: Meter.;Fecal butyrate. Timepoint: At the baseline and after 8 weeks. Method of measurement: Gas-chromatography-Mass spectrometer.;Fecal propionate. Timepoint: At the baseline and after 8 weeks. Method of measurement: Gas-chromatography-Mass spectrometer.;Fecal acetate. Timepoint: At the baseline and after 8 weeks. Method of measurement: Gas-chromatography-Mass spectrometer.—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.Seyedeh Neda Mousavi

Zanjan University of Medical Sciences

neda.mousavi@zums.ac.ir+98 24 3377 2020

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026